Use this link to cite:
http://hdl.handle.net/2183/21786 Sofosbuvir/ledipasvir plus ribavirin achieves high SVR12 in genotype‐3 patients with compensated cirrhosis and similar to sofosbuvir plus daclatasvir: a multicentre real life cohort
Loading...
Identifiers
Publication date
Authors
Riveiro-Barciela, M.
Alonso, Sonia
Fernández, Inmaculada
Rincón, D.
Real, Yolanda
Crespo, Javier
Gea, F.
Olveira, Antonio
Calleja-Panero, José Luis
Polo Lorduy, B.
Advisors
Other responsabilities
Journal Title
Bibliographic citation
Riveiro-Barcela M, Alonso S, Fernández I, et al. Sofosbuvir/ledipasvir plus ribavirin achieves high SVR12 in genotype‐3 patients with compensated cirrhosis and similar to sofosbuvir plus daclatasvir: a multicentre real life cohort. En: The 67th Annual Meeting of the American Association for the Study of Liver Diseases: the Liver Meeting 2016; 2016 Nov 11-15; Boston, Massachusetts. Hoboken, NJ: John Wiley & Sons; 2016. p. 464A (Heaptology. 2016; 64 Special issue 1)
Type of academic work
Academic degree
Abstract
Description
Poster abstract
Keywords
Rights
This is the peer reviewed version of the article which has been published in final form at Hepatology. This article may be used for non-commercial purposes in accordance with Wiley Terms and Conditions for self-archiving